{"chunk_id": "medquad__chunk_33029", "source": "medquad", "text": "ns. The U.S. Food and Drug Administration has approved pasireotide diasparate, taken by injection, for individuals who cannot be helped through surgery.\",NINDS,Cushing's Syndrome\nWhat is the outlook for Cushing's Syndrome ?,\"The prognosis for those with Cushing's syndrome varies depending on the cause of the disease. Most cases of Cushing's syndrome can be cured. Many individuals with Cushing's syndrome show significant improvement with treatment, although some may find recovery complicated by v"}